4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-24-004287
Chief Scientific Officer sold 787 shares at $1.01 ($793)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Taveras Arthur Chief Scientific Officer | 2024-02-12 | Sale | −787 | $1.01 | $793 | 248,536 | D |
| Open-market sales · 787 sh · avg $1.01 · $793 | |||||||
Loading xslF345X05/wk-form4_1707776584.xml…